KCM Investment Advisors’s Charles River Laboratories CRL Stock Holding History

KCM Investment Advisors’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$204K	Buy	+899	New	+$160K	0.01%	396
2024 Q2	–	Sell	-1,172	Closed	-$318K	–	372
2024 Q1	$318K	Hold	1,172	–	–	0.01%	315
2023 Q4	$277K	Hold	1,172	–	–	0.01%	322
2023 Q3	$230K	Hold	1,172	–	–	0.01%	342
2023 Q2	$246K	Hold	1,172	–	–	0.01%	355
2023 Q1	$237K	Hold	1,172	–	–	0.01%	378
2022 Q4	$255K	Hold	1,172	–	–	0.01%	357
2022 Q3	$231K	Hold	1,172	–	–	0.01%	343
2022 Q2	$251K	Sell	1,172 -56	-5%	-$13.7K	0.01%	355
2022 Q1	$349K	Buy	1,228 +40	+3%	+$12.3K	0.01%	337
2021 Q4	$448K	Hold	1,188	–	–	0.02%	303
2021 Q3	$490K	Hold	1,188	–	–	0.02%	273
2021 Q2	$439K	Hold	1,188	–	–	0.02%	283
2021 Q1	$344K	Hold	1,188	–	–	0.02%	294
2020 Q4	$297K	Hold	1,188	–	–	0.01%	290
2020 Q3	$269K	Buy	+1,188	New	+$247K	0.01%	278

Other funds holding CRL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

KCM Investment Advisors's CRL Position: Q2 2026 in Review

KCM Investment Advisors opened a new position in Charles River Laboratories (CRL) in Q2 2026: 899 shares worth $204K. The stake represents 0.01% of the portfolio and ranks #396 among its holdings. This is a return to the name: KCM Investment Advisors previously reported a position in CRL as recently as Q1 2024.

KCM Investment Advisors first reported a position in CRL in Q3 2020 and has held it in 16 quarters since. The position peaked at $490K in Q3 2021. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

KCM Investment Advisors held 899 shares of Charles River Laboratories worth $204K as of Q2 2026.
Charles River Laboratories was a new KCM Investment Advisors position in Q2 2026.
Charles River Laboratories made up 0.01% of KCM Investment Advisors's portfolio in Q2 2026, its #396 holding.
KCM Investment Advisors first reported a position in Charles River Laboratories in Q3 2020 and has held it in 16 quarters since.
KCM Investment Advisors's Charles River Laboratories position peaked at $490K in Q3 2021.
570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on KCM Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.